Evonik and Heraeus Precious Metals are collaborating to expand both companies’ range of services for highly potent active pharmaceutical ingredients (HPAPIs). The cooperative effort leverages the specific HPAPI competencies of both companies and provides customers with a fully integrated offering from the pre-clinical stage to commercial manufacturing. Customers will benefit from a streamlined transfer between small and large-scale production between the two companies which is based on an understanding of each other’s capabilities and assets, as well as the proximity of the Hanau manufacturing sites.
Heraeus expands capacity for platinum-based active pharmaceutical ingredients to treat cancer
Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients (Pt HPAPIs) with an additional production line built at the company’s headquarters in Hanau, Germany.